Showing results (251-260 of 2,409) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|December 27, 2017
Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and ItalySebastian Gonzalez-McQuire, Kwee Yong, Henri Leleu, et al.Journal of Medical Economics|November 17, 2009
Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipationA M Rentz, R Yu, S Müller-Lissner, et al.Journal of Medical Economics|July 21, 2025
Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in GermanyJohnna Perdrizet, Dominik Schröder, Felicitas Kühne, et al.Journal of Medical Economics|June 5, 2025
A cost-effectiveness analysis of deucravacitinib vs. apremilast in moderate-to-severe psoriasis patients in JapanGijs van de Wetering, Hyunchung Kim, David Roberts, et al.Journal of Medical Economics|June 6, 2025
Economic impact of in-office pediatric tympanostomy tube placement using a tympanostomy tube delivery device in a commercially- and Medicaid-insured US populationMeghan Moynihan, Ryan Ross, Joseph Delgado, et al.Journal of Medical Economics|October 7, 2025
Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's disease (aPD): demonstration of savings from a societal perspective in the UKK Ray Chaudhuri, Lars Bergmann, Jonathan Belsey, et al.Journal of Medical Economics|October 20, 2025
Cost-effectiveness of non-statin lipid-lowering therapies as an add-on to statins for achieving low-density lipoprotein cholesterol therapeutic targets in very high-risk patients in the Spanish settingMónica Climente-Martí, Xandra García-González, Francisco Ignacio Torres-Bondia, et al.Journal of Medical Economics|September 25, 2025
The incremental net monetary benefit of higher-valent pneumococcal conjugate vaccines for adults: a systematic review and meta-analysis of economic evaluationsHaeseon Lee, Jeong-Yeon Cho, Jeffrey Vietri, et al.Journal of Medical Economics|September 29, 2025
Frequency, duration, and cost of pulmonary exacerbations among patients with bronchiectasisMaitreyee Mohanty, Claudia Leiras, Haiyan Sun, et al.Journal of Medical Economics|July 16, 2025
Projected clinical and economic benefits of improved patent foramen ovale testing among cryptogenic stroke patients in the United StatesJohn J Volpi, Scott E Kasner, Tjeerd Looman, et al.Pageof 241